pharmaceuticals News - The Latest News, Insight, Commentary & Analysis at Healthcare Asia Magazine

pharmaceuticals

Hong Kong pharmaceutical market to be valued at $3b by 2028

However, competition from neighbouring markets poses downside risks.

AI to accelerate drug discovery and development timelines

Over 3,000 drugs have been developed or repurposed using AI.

Malaysian pharmaceutical market to project modest growth amidst new reform

A new procurement system aims to address medicine shortages and supply chain disruptions.

Skills shortage hinders digital transformation in the pharma industry

Large and medium-sized companies view this as a greater concern compared to smaller enterprises.

South Korea’s pharmaceutical sales to hit $40.6b by 2028

It is expected to rise at a compound annual growth rate of 10% in US dollar terms.

7MM Parkinson’s disease pipeline focuses on disease-modifying agents

There are a total of 93 products in Phase I-III development for PD treatment.

India’s pharmaceutical sector faces challenges amidst weak IP regime

Applicants seeking market approval encounter uncoordinated processes amongst federal and state agencies.

Mainland China’s pharmaceutical sales to hit $345b by 2033

Global drugmakers seek partnerships to boost their presence in the world's second-largest pharmaceutical market.

SingHealth launches new College of Clinical Pharmacy

It will focus on areas such as precision medicine, digital health, and medical humanities.

India-based drugmakers urged to improve standards amidst quality scrutiny

This follows cases of drug toxicity, resulting in fatalities in Central Asia, North America, and Africa.

What factors drive the hormone replacement therapy market?

One key factor is the growing ageing population, particularly in developed countries.

China emerges as key player in oncology with antibody-drug conjugates surge

It represents 82% of the ADC pipeline in major APAC markets.

Atopic dermatitis market to reach $16.7b by 2030 across seven major markets

Pharmaceutical firms are urged to capitalise on current trends in AD trials.

Sepsis drug development remains challenged amidst high trial failures

Currently, there are 14 drugs in late-stage development across eight major markets.